Sitosterolemia and xanthomatosis are characterized by the development of tendon and tuberous xanthomas at an early age and premature atherosclerosis despite normal plasma cholesterol concentrations. The reason(s) for the xanthoma formation and premature atherosclerosis are not clearly understood. The accumulation of sitosterol in the tissues of these patients could be due to increased uptake of low density lipoprotein (LDL) via LDL receptors because of an expanded sitosterol pool caused by sluggish turnover and decreased excretion of sitosterol into bile and feces coupled with the hyperabsorption of sitosterol. We have studied sitosterol and cholesterol turnovers, the biliary and fecal excretion of neutral and acidic steroids, and the response of plasma sterol (sitosterol and cholesterol) levels to either a sterol-free formula or low plant sterol diet in three patients. The average half-life of the first exponential (t A l/2) for sitosterol was 9.2 ±3.3 (mean±SD) days, which was more than twice that in normal humans. The second exponential (t B l/2) was 156±108 days, which was nearly 10 times longer than that for normal humans. The average cholesterol production rate in pool A was 0.87 g/day, which is about 40% of that in normal humans. Cholesterol synthesis measured by the sterol balance technique was also found to be about 70% lower than that for normal humans. In two patients fed a sterol-free formula diet, by 25 days their plasma sitosterol and cholesterol levels had decreased by 42% and 36%, respectively. However, in one patient plasma sitosterol and cholesterol concentrations remained unchanged while on the low plant sterolmixed food diet. The sitosterol to cholesterol ratio in bile (0.05) was extremely low compared with that found in plasma (0.14), indicating low excretion of sitosterol into the bile. Thus, patients with sitosterolemia have a slow turnover of sitosterol, low excretion of sitosterol into the duodenal bile and feces, and low cholesterol synthesis. These metabolic defects have implications in the formation of xanthomas and the development of premature atherosclerosis in these patients. (Arteriosclerosis and Thrombosis 1991;11:1287-1294)
all of these patients have been well summarized. 11 -13 In brief, the disease is characterized by markedly elevated plant sterol concentrations in blood and tissues (other sterols have also been found in plasma), the development of tendon and tuberous xanthomas at an early age, and the development of premature cardiovascular disease. Heterozygous subjects have been reported to have hyperapobetalipoproteinemia. 9 The disease is inherited as an autosomal recessive disorder. 211 Previously we demonstrated that increased intestinal absorption of dietary sitosterol is one major metabolic defect in this disease. 2 High intestinal absorption of sitosterol in sitosterolemic patients has been confirmed by other investigators. 410 In addition, it has been suggested that biliary excretion of sitosterol is limited in these patients. 411 " 13 This finding is in contrast to what has been reported for normal humans. 14 We therefore postulated that the metabolic defect(s) in this disease could be a combination of hyperabsorption, slow turnover, and low excretion of sitosterol. The combination of these defects along with the increased low density lipoprotein (LDL) receptor activity in sitosterolemic cells as shown by Nguyen et al 15 may explain the accumulation of sitosterol and cholesterol in the tissues, including the arteries, producing xanthomas and atherosclerosis. In this article, we report studies of three sitosterolemic patients in terms of 1) the turnover of sitosterol and cholesterol; 2) the response of plasma sterol levels to the feeding of low plant sterol-mixed food or sterol-free formula diets; and 3) the excretion of sitosterol in bile and the fecal excretion of plant sterols, neutral sterols (cholesterol and its bacterially modified products, coprostanol and coprostanone), and bile acids.
Methods

Patients
Three patients, the two sisters originally identified (patients No. 1 and 2 in Reference 2) and a third patient subsequently identified (patient No. 3 in Reference 3), were studied. At the time of these studies, the three patients were 25, 23, and 33 years old; their body weights were 68,67, and 65 Kg; and their heights were 165, 167, and 161 cm, respectively. The clinical data and the plasma and tissue sterol levels of the three patients have been reported previously in detail. 2 ' 313 In two of the three patients, in addition to plant sterols in the plasma, no other sterols except for cholestanol in normal amounts (<1 mg/dl) were detected under our analytical conditions.
Diets
The habitual diets of these patients provided approximately 35% of calories from fat, about 544 mg/day of cholesterol, and about 200 mg/day of total plant sterols.
The low plant sterol-mixed food diet consisted of meat, fish, dairy products, eggs, and vegetables low in fat. In essence, this diet was devoid of food items such as margarine, salad oil and dressing, nuts, and vegetable oils containing high amounts of plant sterols. The estimated cholesterol content of the diet was about 600 mg. The plant sterol intake was estimated to be between 20 and 25 mg/day. The composition and sample menus of the prescribed low plant sterol-mixed food diet has been previously described. 13 The sterol-free formula diet provided fat (solely derived from stripped lard) at 40% of total caloric intake, protein at 15%, and carbohydrates at 45%, together with 8 g cellulose, vitamins, and mineral supplements to meet all nutritional requirements as previously described. 19 g fat, and 225 mg cholesterol. An aliquot of the formula was analyzed for radioactivities to obtain the exact amounts of radioactive sterols in the breakfast formula. After the isotopic formula was fed, the residual radioactivities in the containers and equipment were determined. These amounts were subtracted from the amount of radioactivities in the breakfast formula to obtain the exact doses of radioactive sterols fed. After feeding of the isotopic meal, feces were collected daily for 7 days. The 7-day pooled feces were analyzed for radioactivities as described below. The differences between the amounts of radioactive sterols fed and the amounts excreted in the 7-day pooled feces were used to calculate the turnovers of sitosterol and cholesterol as described below.
Blood was drawn (5 consecutive days after administration of the isotopic meal, followed by weekly sampling for 6 weeks and then 2-3 weeks apart for another 7-9 weeks, for a total of 18-20 blood samples) to determine plasma sterol (sitosterol and cholesterol) specific activities as described below. The sterol specific activity-decay curves were analyzed by the generalized nonlinear least-squares method of Snedecor and Cochran 18 by use of a computer to fit the logarithm of specific activity to the logarithm of the sum of the exponentials. Sitosterol and cholesterol turnovers were calculated according to the two-pool model. 19 As stated above, whenever required in the study feces were collected daily for 7 consecutive days. Also KAA, rate constant for total removal from pool A; KAB, rate constant for the transfer from pool A to pool B; K A , rate constant for the removal from pool A and the whole system; K B B, rate constant for total removal from pool B; K BA , rate constant for transfer from pool B to pool A.
as required, duodenal bile was obtained by intubation by use of an MgSO 4 solution to enhance bile flow. The procedures were performed while the patients were inpatients in the metabolic ward at the Clinical Research Center. The study was approved by appropriate committees of the institutions for use of human subjects for experimentation. Informed consent was obtained from all patients.
Analytical Methods
Determination of plasma sterol concentrations and radioactivities. Plasma was separated from fasting blood samples by centrifugation at 4°C and stored frozen at -20°C in glass vials for analysis. The plasma sterols were quantified by GLC after saponification and /i-hexane extraction as described previously. 2 The radioactivities were determined for another aliquot of the same plasma extract used for the mass determination by scintillation counting with 10 ml scintillation solution [4 g 2,5-diphenyloxazole and 0.1 g l,4-bis-(5-phenyl-2-oxazolyl)benzene/l toluene] in a liquid scintillation counter (model 3380, Packard Instrument Co., Inc., Downer's Grove, 111.) equipped with an absolute activity analyzer (model 544, Packard Instrument Co., Inc.) and set up for double-label counting.
Determination of plant sterols, cholesterol, and bile acids in duodenal bile. Aliquots of freshly collected duodenal bile samples were taken immediately for lipid analyses. The neutral sterols (cholesterol and plant sterols) and bile acids were analyzed by the methods described previously.
14 Determination of plant sterols, cholesterol, and other neutral sterols and bile acids in feces. The 7-day pooled feces samples were homogenized with water (1:1), and an aliquot was analyzed for neutral sterols and bile acids by the combined method of TLC and GLC. 20 21 To determine the radioactivities of individual bile acids, bile acids were separated by TLC on silica gel G plates with a solution mixture of isooctane/ethyl acetate/acetic acid (10:10:2, vol/vol/ vol). 22 Bile acid bands were visualised, scraped from the plate, and eluted with chloroform/methanol (1:1, vol/vol). Radioactivities were counted in the eluates as described above.
Results
Sitosterol and Cholesterol Turnovers
These studies were performed while the patients were consuming their habitual diet. Sitosterol turnover was calculated from the plasma sitosterol specific activity-decay curve (Table 1) by use of the two-pool model. 19 The half-lives of the two exponentials varied between 5 and 12 days for t A l/2 (mean±SD, 9.2±3.3 days) and between 78 and 280 days for t B l/2 (mean±SD, 156±109 days). The size of the rapidly exchangeable pool (M A ) ranged between 1,354 and 2,664 mg (mean±SD, l,962±660 mg), and that of the total exchangeable pool was between 4,704 and 6,284 mg (mean±SD, 5,437±796 mg). The production rate of sitosterol in pool A varied between 19.9 and 51.7 mg/day (mean±SD, 36.1 ±15.9 mg/day) in the three patients.
The parameters of cholesterol turnover in two patients are shown in Table 2 . The average half-lives for the two exponentials, t A l/2 and t B l/2, were 4.5 and 60 days, respectively. The mean size of pool A was 25.3 g, and that of the total exchangeable pool was 63.3 g. The mean production rate of cholesterol in pool A was 0.87 g/day.
Effects of Feeding Low Plant Sterol-Mixed Food or Sterol-Free Formula Diets on Plasma Sterol Concentrations
Patients No. 2 and 3 were fed a sterol-free eucaloric formula diet. In patient No. 2, 2 weeks of feeding of the sterol-free formula diet produced no change in the plasma sitosterol level (14.5 mg/dl at the beginning versus 13.9 mg/dl at the end of 2 weeks) ( Figure 1 ). However, plasma cholesterol concentration decreased from 250 mg/dl to about 200 mg/dl by the end of the 2-week period. After the sterol-free formula diet was continued for another 4 weeks, the plasma sitosterol and cholesterol levels decreased to about 8 and 160 mg/dl, respectively. Plasma campesterol concentration also decreased slightly, from about 5.5 to 3.6 mg/dl during the sterol-free diet period (data not shown). Stigmasterol concentration in the plasma remained as a trace. Patient No. 3 behaved similarly on the sterol-free formula diet (Figure 1, lower panel) . Her plasma sitosterol and cholesterol concentrations decreased from 10.9 to 6.4 mg/dl and from 280 to 184 mg/dl, respectively, by 25 days on the sterol-free formula diet. Within a month of her discharge from the hospital, the plasma sterol levels approached their initial higher values.
Patient No. 1 who was on the low plant sterolmixed food diet, however, behaved differently; her plasma sitosterol and cholesterol levels (14.5 and 202 mg/dl, respectively) remained unchanged during the 9 weeks on the diet.
Concentrations of Plant Sterols and Cholesterol in Duodenal Bile
These measurements were made while the patients were consuming their habitual diet. In patient No. 1, sitosterol was not detected in any measurable amount in the duodenal bile; cholesterol was the only sterol present (4.0 mg/dl bile) ( Table 3 ). In patients No. 2 and 3, sitosterol concentrations in the duodenal bile were 0.21 and 0.12 mg/dl, respectively; campesterol levels were 0.13 and 0.09 mg/dl, and stigmasterol was present in trace amounts. The ratio of sitosterol to cholesterol in duodenal bile was 0.05 compared with 0.14 in the plasma of the two patients.
Fecal Excretion of Plant Sterols, Neutral Sterols, and Bile Acids
While consuming their habitual diet, the two patients (Nos. 2 and 3) excreted between 140 and 210 mg plant sterols/day in feces (Figure 2) . The sterolfree formula diet produced an immediate and sharp decline in the fecal excretion of plant sterols. The daily fecal excretion of plant sterols remained low, so long as the sterol-free formula feeding was continued (Figure 2 ). The mean plant sterol excretion at the seventh and eighth weeks after the sterol-free diet Table 4 shows the fecal excretion of neutral sterols (cholesterol and its bacterially modified products) and bile acids in two patients fed the sterol-free formula diet. The daily fecal excretion of neutral 
Habitual
Weeks an
Sierol-Free Formula Diet
FIGURE 2. Bar graphs showing amount of fecal excretion of plant sterols in sitosterolemic patients 2 (upper panel) and 3 (lower panel) on their habitual average American diet and on the sterol-free formula diet.
sterols and bile acids averaged 119 and 72 mg/day, respectively, or about 1.8 and 1.1 mg/day/kg body wt in the two patients compared with 447 and 298 mg/day, or 6.3 and 4.4 mg/day/kg body wt. Table 5 shows the distribution of 14 C radioactivity derived from the [ ]sitosterol was recovered in the fecal acidic sterol fraction. About 6% of the total radioactivity in the acidic sterol fraction was found in the cholic acid spot, 55-60% in the combined chenodeoxycholic and deoxycholic acids spot, and 28-36% in the lithocholic acid spot.
Discussion
Our study shows that in the three sitosterolemic patients, the turnover of sitosterol in the body is extremely sluggish. Compared with normal humans, 23 the half-life of the first exponential of the plasma sitosterol specific activity-decay curve in the sitosterolemic patients is more than two times longer, and that for the second exponential is about 10 times longer. Similarly long half-lives for both exponentials have also been reported previously in a patient with sitosterolemia and cholestanolemia. 10 Second, the greatly expanded pool of sitosterol (Table 1) is probably the consequence of its slow turnover. Salen and colleagues 26 have recently reported that the slow turnover of sitosterol in these patients causes the total exchangeable pool of sitosterol to expand.
The slow turnover of sitosterol in these patients is the result of low excretion of sitosterol into the duodenal bile. Only a trace amount of sitosterol was detected in the duodenal bile of one patient, and in the other two patients sitosterol constituted only 4.5% of total sterols in the duodenal bile (Table 3) , despite the high concentration of sitosterol in the plasma of the patients. Thus, in sitosterolemic patients the ratio of sitosterol to cholesterol in the duodenal bile was extremely low compared with that in the plasma (Table 3) . Also, this ratio in the duodenal bile is extremely low compared with that in normal humans, in whom the ratio was found to be about 17.
14 Thus, in sitosterolemia the daily turnover of sitosterol is extremely sluggish because of low excretion of the sterol into bile. We suggest that hyperabsorption of sitosterol, coupled with its slow turnover because of low excretion into bile, is the cause for the expansion of the plasma pool of sitosterol in patients with the disease.
Although the mechanism for the development of xanthomas and atherosclerosis is not clearly understood, we believe that due to this increased plasma pool, the accumulation of sitosterol in the tissues, including the arteries, occurs by increased uptake of LDL via LDL receptors, 15 causing further accumulation of cholesterol in tissues and subsequent production of xanthomas 27 and atherosclerosis in these patients. Previously, we reported that about 76% of plasma sitosterol is carried in LDLs. 2 We suggested that perhaps the accumulation of plant sterols in the tendons and arteries may have caused increased cholesterol deposition in these tissues either by attracting more cholesterol from plasma by way of net transfer or by stimulating biosynthesis of cholesterol locally. 2 Both these processes could occur in the presence of normal plasma cholesterol levels. Furthermore, perhaps the high concentration of plant sterols in the plasma LDL may have affected the stability of these lipoproteins, thereby favoring the deposition of these sterols into tissues. Furthermore, Kwiterovich et al 9 suggested that in sitosterolemia there may be an increased number of LDL particles of abnormal composition, particularly raised LDL B protein.
The reason for the low excretion of sitosterol into bile by the liver is not clearly understood. Long ago, Salen et al 23 suggested that mechanism(s) exist in the liver of normal humans whereby sitosterol is preferentially selected for rapid excretion as a neutral sterol into bile. Lin et al 14 also reported that in normal humans, both shellfish and plant sterols are selectively excreted into bile. Thus, in this disease this mechanism(s), that is, the ability of the liver to preferentially excrete plant sterols into bile, is impaired. Recently, Salen et al 26 postulated that the decreased hepatic sterol excretion into bile helps conserve sterols in the body because of the reduced cholesterol synthesis observed in patients with sitosterolemia. In this respect the hypothesis proposed by Gregg and colleagues 28 is also noteworthy. These investigators have proposed that in sitosterolemia there is loss of recognition of the structure of different sterols, which leads to increased intracellular esterification of sterols. The esterified sterols are held over in the tissues because sterol excretion occurs primarily in the free form. The site(s) and reasons for the loss of sterol structure recognition, however, remain unknown.
The low excretion of sitosterol into bile was also reflected in the fecal excretion of this sterol in sitosterolemic patients when they were fed the sterolfree formula diet. As soon as the sterol-free formula diet was started, the fecal excretion of plant sterols decreased drastically to 10-25 mg/day, from 150-200 mg/day on the habitual diet, and continued to be low so long as the sterol-free formula diet was continued ( Figure 2 ). This is in contrast to our observation in normal human subjects and hyperlipoproteinemic patients, in whom the sterol-free formula diet produced a complete absence of plant sterols in the feces by 4 weeks. 29 Furthermore, the feces of those subjects remained completely devoid of plant sterols, so long as the formula diet was sterol-free. 29 Therefore, the continued low excretion of plant sterols in the feces in sitosterolemic patients while they were fed the sterol-free formula diet suggested that there was a depletion of plant sterols from the tissue pools. This finding has important implications for the dietary therapy of this disease.
The presence of 14 C radioactivity in the acidic sterol fraction of duodenal bile and of the feces after feeding of [ sented in Table 5 suggest that the bile acids derived from sitosterol are the same ones that are normally produced from cholesterol, namely cholic and chenodeoxycholic acids. These results are in agreement with those reported in normal and hyperlipidemic patients by Salen et al. 23 In our patients, only 8-13% of the absorbed radioactive sitosterol dose was found in the fecal acidic sterol fraction compared with 20% in normal and hyperlipidemic subjects, as reported by Salen et al. 23 Therefore, there may also be an impairment in the liver with respect to the metabolic conversion of sitosterol into primary bile acids in sitosterolemia.
Subbiah et al 30 reported that in the rat liver, the bile acids formed from intravenously injected sitosterol were not identical with natural bile acids formed from cholesterol. They suggested that the bile acids formed in the rat liver from sitosterol were mono-, di-, and trihydroxy derivatives of 24-ethylcoprostanoic acid. 3031 In humans it appears that bile acids formed from sitosterol are similar to those synthesized from cholesterol. The pathway for the conversion of sitosterol into primary bile acids remains to be elucidated in humans.
Cholesterol turnover in the sitosterolemic patients (Table 2 ) also appeared sluggish compared with that reported in normal humans. 24 In both patients, the total exchangeable pool of cholesterol, production rate of cholesterol in pool A, and the rate constant for the removal of cholesterol from pool A and the whole system (K A ) are low compared with those in normal humans ( Table 2 ). The average cholesterol production in pool A in our patients was 0.87 mg/day, which is 40% of that reported for normal subjects. 24 Cholesterol synthesis measured by the sterol balance technique (Table 4) was also found to be 30% of normal production. 25 These results are in agreement with those reported by Salen et al, 26 Miettinen, 4 and Lin and coworkers. 10 According to Nguyen and colleagues, 15 the low cholesterol synthesis in sitosterolemic patients is associated with a markedly reduced microsomal hydroxymethyl glutaryl-coenzyme A (HMG-CoA) reductase activity, the rate-controlling enzyme for cholesterol biosynthesis. Recently, Nguyen and colleagues 32 have reported that hepatic microsomal HMG-CoA reductase is markedly decreased because of low levels of mRNA that translate for its synthesis. Previously, Brown and Goldstein 33 had shown that sitosterol inhibited HMG-CoA reductase activity, although less than cholesterol, in normal and homozygous hypercholesterolemic human skin fibroblasts. The reduced HMG-CoA reductase activity in the sitosterolemic leukocytes, as observed by Nguyen et al, 15 could therefore be due to the presence of high concentrations of sitosterol in these cells. We have shown previously that sitosterolemic red blood cells contain large amounts of sitosterol 2 ; therefore, it would not be surprising to find large amounts of sitosterol in sitosterolemic leukocytes. On the contrary, recently Boberg et al 34 reported that sitosterol dissolved in soybean oil by sonication and mixed with Intralipid 10% administered intravenously to rats failed to suppress HMG-CoA reductase activity. In fact, their results indicated that the enzyme activity was slightly increased, although the increase was not statistically significant. In this respect, it is worth noting that all animal studies to date have shown that sitosterol is not absorbed in any significant amount; instead, campesterol is the plant sterol that is absorbed more than sitosterol. 3135 - 41 Patients with sitosterolemia, in contrast, absorb large amounts of sitosterol. 2410 Thus far, no animal model has been found mimicking the disease as manifested in humans.
In summary, our study shows that the turnover of sitosterol in sitosterolemic patients is extremely sluggish. This slow turnover is the result of the defective excretion of plant sterols by the liver into the bile, either as neutral sterols or as derived bile acids, resulting in low excretion of sitosterol in the feces. Also as a consequence of this low excretion of sitosterol from the body, the plasma pool expands, which makes possible the increased uptake of LDL via LDL receptors 15 by the tissues, including the arteries, causing accumulation of sitosterol and cholesterol-producing xanthomas 27 and atherosclerosis in these patients.
